Recognising the substantial burden of neglected pandemics cystic and alveolar echinococcosis.

08:00 EDT 1st April 2020 | BioPortfolio

Summary of "Recognising the substantial burden of neglected pandemics cystic and alveolar echinococcosis."

No Summary Available


Journal Details

This article was published in the following journal.

Name: The Lancet. Global health
ISSN: 2214-109X
Pages: e470-e471


DeepDyve research library

PubMed Articles [6035 Associated PubMed Articles listed on BioPortfolio]

Epidemic cystic and alveolar echinococcosis in Kyrgyzstan: an analysis of national surveillance data.

Human cystic and alveolar echinococcosis are among the priority neglected zoonotic diseases for which WHO advocates control. The incidence of both cystic echinococcosis and alveolar echinococcosis has...

Frequency and clinical presentation of alveolar and cystic echinococcosis in a tertiary medical center in Germany 2004-2018: lessons from a low-prevalence area.

 The prevalence of alveolar echinococcosis (AE) and cystic echinococcosis (CE) in Germany is increasing. The number of cases in northern and eastern regions is low, so there is little experience wit...

Cystic and alveolar echinococcosis are two completely different diseases cause by two different species of Echinococcus parasites. COMMENT ON: Disseminated cystic echinococcosis of Ferdinando II de' Medici, Grand Duke of Tuscany (1610-1670) by Gaeta R, Giuffra V. J Infect. 2019 Sep 4.

Disease burden of echinococcosis in Tibetan communities-a significant public health issue in an underdeveloped region of western China.

Echinococcosis is considered by the World Health Organization (WHO) to be a neglected zoonotic disease in the world. Some Tibetan communities were found to be highly endemic for echinococcosis just 20...

An integrated surgical training program for hepatic cystic echinococcosis in Xinjiang of China.

Human cystic echinococcosis (CE) is one of the commonest zoonoses, and it is endemic in many parts of the world including China. Complications and recurrences after the surgical treatment of hepatic C...

Clinical Trials [3548 Associated Clinical Trials listed on BioPortfolio]

Alveolar Echinococcosis: Parasite Viability and Innovative Markers for the Follow-up of Patients Treated With Albendazole

Study design to define improved management of patients with hepatic alveolar echinococcosis treated with albendazole and especially make appropriate and timely decision of treatment withdr...

Periprosthetic Fracture Following Tibial Echinococcosis

Cystic Echinococcus in the bone is rare, comprising 0.5% to 2.5% of all human hydatidosis Association of Hydatid disease to pathologic fractures involving knee prosthesis have not yet been...

Parameters to Assess Response to Intra-Venous Antibiotic Treatment for Pulmonary Exacerbations in Cystic Fibrosis

Cystic fibrosis (CF) is a multisystem disease characterized by viscid secretions in multiple organ systems. Lung infection and damage account for most of the disease burden. Acute changes ...

19F MRI to Evaluate Regional Ventilation in Healthy Subjects and Subjects With Cystic Fibrosis

An open label non-randomized study enrolling up to 20 healthy participants and up to 30 participants with cystic fibrosis to establish a healthy versus disease comparison. Each participant...

Autogenous Bone Mixed With Xenograft Versus Xenograft Alone Versus Absorbent Gelatin Sponge

Alveolar bone atrophy post-extraction has been well documented in the past years. normal healing event results in a minimal loss of vertical height (around 1 mm), but a substantial loss of...

Medical and Biotech [MESH] Definitions

Administration of a medication to at-risk individuals in a population without individual diagnosis. It is often used in order to treat, control, and/or prevent spread of often endemic DISEASE OUTBREAKS such as NEGLECTED DISEASES in high disease burden areas.

Measure of the burden of disease using the disability-adjusted-life-year (DALY). This time-based measure combines years of life lost due to premature mortality and years of life lost due to time lived in states of less than full health. The metric was developed to assess the burden of disease consistently across diseases, risk factors and regions.

Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).

Small polyhedral outpouchings along the walls of the alveolar sacs, alveolar ducts and terminal bronchioles through the walls of which gas exchange between alveolar air and pulmonary capillary blood takes place.

A cystic growth originating from lymphatic tissue. It is usually found in the neck, axilla, or groin.

Quick Search

DeepDyve research library

Searches Linking to this Article